These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Combined liver damage from primary biliary cirrhosis, primary sclerosing cholangitis, liver allograft rejection and graft-versus-host disease]. Kogan J, Ilan I. Harefuah; 2000 Jan 02; 138(1):38-41. PubMed ID: 10868178 [No Abstract] [Full Text] [Related]
3. Destruction of bile ducts in primary biliary cirrhosis. Nakanuma Y, Tsuneyama K, Sasaki M, Harada K. Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug 02; 14(4):549-70. PubMed ID: 10976014 [Abstract] [Full Text] [Related]
4. The role of cholangiocytes in the development of chronic inflammatory liver disease. Adams DH, Afford SC. Front Biosci; 2002 Jul 01; 7():e276-85. PubMed ID: 12086915 [Abstract] [Full Text] [Related]
11. Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors. Schimmer AD, Thomas MP, Hurren R, Gronda M, Pellecchia M, Pond GR, Konopleva M, Gurfinkel D, Mawji IA, Brown E, Reed JC. Cancer Res; 2006 Feb 15; 66(4):2367-75. PubMed ID: 16489043 [Abstract] [Full Text] [Related]
13. Significant inhibition of human CD8(+) cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen. Kawamoto K, Tanemura M, Nishida T, Fukuzawa M, Ito T, Matsuda H. Transplantation; 2006 Mar 15; 81(5):789-96. PubMed ID: 16534484 [Abstract] [Full Text] [Related]